Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
semaglutide
Research
How GLP-1s help the heart relax: study
Giving GLP-1 mimic exendin-4 to rodents with constricted blood vessels caused their capillaries to relax back to a normal state.
Darren Incorvaia
Mar 2, 2026 7:01pm
Novo's CagriSema loses phase 3 obesity battle against Zepbound
Feb 23, 2026 7:20am
Novo’s CagriSema tops semaglutide in ph. 3 diabetes study
Feb 2, 2026 3:01pm
Fierce Pharma
Novo reports 2 trial failures for GLP-1 in Alzheimer's disease
Nov 24, 2025 11:41am
Ventyx's CV drug rapidly reduces cardio risk biomarker
Oct 23, 2025 9:45am
Skye's CB1 blocker fails to reduce weight in obesity study
Oct 6, 2025 7:55am
